![Stéphane Paquette](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stéphane Paquette
Investor Relations Contact chez
KRYSTAL BIOTECH, INC.
Profil
Stéphane Paquette is currently SVP-Corporate Development, Head-Investors & Media at Krystal Biotech, Inc. Formerly, Dr. Paquette was Director-Business Development at Appili Therapeutics, Inc. from 2019 to 2020.
Education includes undergraduate studies at McGill University and a doctorate from the University of Toronto.
Postes actifs de Stéphane Paquette
| Sociétés | Poste | Début |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Investor Relations Contact | - |
Anciens postes connus de Stéphane Paquette
| Sociétés | Poste | Fin |
|---|---|---|
| APPILI THERAPEUTICS INC. | Corporate Officer/Principal | 01/09/2020 |
Formation de Stéphane Paquette
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Appili Therapeutics, Inc.
 Appili Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for infectious disease | Health Technology |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
